Patents by Inventor A Reum Han

A Reum Han has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240067668
    Abstract: The present invention relates to a heteroaryl derivative compound and a use thereof. Since the heteroaryl derivative of the present invention exhibits excellent inhibitory activity against EGFR, the heteroaryl derivative can be usefully used as a therapeutic agent for EGFR-associated diseases.
    Type: Application
    Filed: December 29, 2021
    Publication date: February 29, 2024
    Inventors: Yi Kyung Ko, Ah Reum Han, Jin Hee Park, Yeong Deok Lee, Hye Rim Im, Kyun Eun Kim, Dong Keun Hwang, Su Been Nam, Myung Hoe Heo, Se Rin Cho, Eun Hwa Ko, Sung Hwan Kim, Hwan Geun Choi
  • Publication number: 20240033433
    Abstract: According to the present disclosure, by a simple operation of pressing the press-fitting block with the pressing part, a press-fitting force of the press-fitting block is automatically released at a predetermined time after the needle part penetrates a skin layer, due to the release of the press-fitting force of the press-fitting block, a practitioner can easily determine a. time to detach and separate the needle part, due to guiding of the time to detach and separate the needle part, even an unskilled person can easily use the microneedle, by a uniform amount of drug being injected into patients, the same therapeutic effect can be given to the patients, and in particular, by the needle part being promptly removed after the drug of the needle part is injected into the skin layer, there is no concern about the needle part staying in the skin layer for an excessive amount of time.
    Type: Application
    Filed: March 25, 2022
    Publication date: February 1, 2024
    Applicant: THERAJECT ASIA Co., Ltd.
    Inventors: Kyung Dong KIM, A Reum HAN
  • Publication number: 20240001402
    Abstract: The present invention relates to a moisture and oxygen barrier laminate with improved durability and flexibility. According to the present invention, there is provided a laminate, comprising: an inorganic barrier layer and a protective layer sequentially formed on one surface of a transparent substrate, wherein the protective layer includes an organic copolymer containing a repeating unit derived from a siloxane compound. The laminate according to the present invention can maintain excellent interlayer adhesion even when deformation such as bending is applied, thereby exhibiting excellent moisture and oxygen barrier properties.
    Type: Application
    Filed: December 9, 2021
    Publication date: January 4, 2024
    Inventors: Ah Reum HAN, Chang Won
  • Publication number: 20230404761
    Abstract: Proposed is a modular augment, and, more specifically, a modular augment in which an additional unit is separably coupled to a center unit so as to selectively couple the additional unit to the center unit according to the degree of a patient's bone loss so that the degree of bone reinforcement can be easily adjusted, and thus a manufacturer is capable of covering various types of patients even though the types of units are minimized, thereby reducing manufacturing costs, the number of products to be prepared for surgery by a user such as a hospital is remarkably reduced, thereby preventing the unnecessary costs and facilitating inventory management, and a patient can receive an optimal augment that is appropriate for the patient' condition.
    Type: Application
    Filed: August 27, 2021
    Publication date: December 21, 2023
    Inventors: Yong In, Jong-Min Kim, Jae-Ang Sim, Jun-Kyu Park, Young-Woong Jang, Ah-Reum Han, Jung-Sung Kim
  • Publication number: 20230116422
    Abstract: A method for operating a memory includes determining to perform an error correction operation; determining whether to perform an error correction operation; generating an internal address when the error correction operation is performed; reading data from memory cells that are selected based on the internal address and an error correction code corresponding to the data; performing an error correction operation on the data based on the error correction code to produce an error-corrected data; writing the error-corrected data and an error correction code corresponding to the error-corrected data into the memory cells; determining one or more regions among regions in the memory as a repair-requiring region based on an error detected when the error correction operation is performed; receiving a first command; backing up the data and the error correction code into a redundant region in response to the first command; and repairing the repair-requiring region with the redundant region.
    Type: Application
    Filed: December 8, 2022
    Publication date: April 13, 2023
    Inventors: Kyung Whan KIM, Sun Hwa PARK, Kee Yun KIM, Sung Joo HA, Ah Reum HAN
  • Publication number: 20230065440
    Abstract: A method for managing an application executed in a user terminal according to an embodiment of this disclosure includes executing a launcher application on the user terminal, displaying a first application list within a first GUI of the launcher application, installing, in the user terminal, a first application selected by a user from applications included on the first application list, displaying a second application list within a second GUI of the launcher application and executing a second application selected by the user from applications included on the second application list.
    Type: Application
    Filed: July 20, 2022
    Publication date: March 2, 2023
    Inventors: Jae Chun OH, A Reum HAN, Sung Pyo LEE, Hye Mi SEO, Hye Jung JUNG, Go Eun LEE, Da In UM, Jung Jun LEE, Ah Ra KO, Joo Yong PARK, Hee Suk JEONG
  • Patent number: 11557366
    Abstract: A method for operating a memory includes determining to perform an error correction operation; determining whether to perform an error correction operation; generating an internal address when the error correction operation is performed; reading data from memory cells that are selected based on the internal address and an error correction code corresponding to the data; performing an error correction operation on the data based on the error correction code to produce an error-corrected data; writing the error-corrected data and an error correction code corresponding to the error-corrected data into the memory cells; determining one or more regions among regions in the memory as a repair-requiring region based on an error detected when the error correction operation is performed; receiving a first command; backing up the data and the error correction code into a redundant region in response to the first command; and repairing the repair-requiring region with the redundant region.
    Type: Grant
    Filed: October 20, 2020
    Date of Patent: January 17, 2023
    Assignee: SK hynix Inc.
    Inventors: Kyung Whan Kim, Sun Hwa Park, Kee Yun Kim, Sung Joo Ha, Ah Reum Han
  • Patent number: 11512112
    Abstract: The peptide of the present invention performs a function, which is the same as or similar to that of natural interleukin (IL)-3, and has superior skin permeability due to the small size thereof. In addition, the peptide of the present invention suppresses the activation of NF-?B and nuclear transition by inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL)-RANK signaling pathway, and suppresses the expression of a RANKL or an inflammatory cytokine-induced tartrate-resistant acid phosphatase (TRAP), cathepsin K, or TNF receptor type 1 or type 2, thereby inhibiting osteoclast differentiation depending on the treatment concentration. Moreover, the peptide of the present invention can contribute to osteoblast differentiation by promoting the expression of osteoblast differentiation markers such as osteocalcin (OCN), osteoprotegerin (OPG), bone sialoprotein (BSP), or osteopontin (OPN).
    Type: Grant
    Filed: April 21, 2020
    Date of Patent: November 29, 2022
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun-Mi Kim, Eung-Ji Lee, Tae-Hoon Lee, A-reum Han
  • Patent number: 11033397
    Abstract: An artificial knee joint includes a tibial component implanted into the proximal end of a tibia, and a bearing component coupled to the tibial component, in which the tibial component includes an interference prevention portion capable of preventing interference with the bearing component when the bearing component is inserted diagonally and the bearing component includes a protrusion coupled to the interference prevention portion.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: June 15, 2021
    Assignee: Corentec Co. Ltd.
    Inventors: Young-Woong Jang, Chan-Eol Kim, Jae-Hun Ro, Ah-Reum Han, Myung-Chul Lee, Yong In, Seung-Beon Han
  • Publication number: 20210158886
    Abstract: A method for operating a memory includes determining to perform an error correction operation; determining whether to perform an error correction operation; generating an internal address when the error correction operation is performed; reading data from memory cells that are selected based on the internal address and an error correction code corresponding to the data; performing an error correction operation on the data based on the error correction code to produce an error-corrected data; writing the error-corrected data and an error correction code corresponding to the error-corrected data into the memory cells; determining one or more regions among regions in the memory as a repair-requiring region based on an error detected when the error correction operation is performed; receiving a first command; backing up the data and the error correction code into a redundant region in response to the first command; and repairing the repair-requiring region with the redundant region.
    Type: Application
    Filed: October 20, 2020
    Publication date: May 27, 2021
    Inventors: Kyung Whan KIM, Sun Hwa PARK, Kee Yun KIM, Sung Joo HA, Ah Reum HAN
  • Patent number: 10957976
    Abstract: Disclosed is a pedestal apparatus having an antenna attached thereto capable of biaxial motion. The pedestal apparatus according to one embodiment may comprise: a body; a first drive unit, arranged on the lower part of the body, for transmitting driving power; a second drive unit, arranged on the lower part of the body, for transmitting driving power; a first drive gear arranged on the upper part of the body and receiving driving power from the first drive unit; a second drive gear arranged on the upper part of the body opposite the first drive gear, and receiving driving power from the second drive unit; and a driven gear which rotates by receiving driving power from the first and second drive gears, and to which an antenna is connected, wherein the antenna can move biaxially in accordance with the rotational directions of the first and second drive gears.
    Type: Grant
    Filed: June 30, 2016
    Date of Patent: March 23, 2021
    Assignee: INTELLIAN TECHNOLOGIES, INC.
    Inventors: Hyun Uk Lee, A Reum Han
  • Publication number: 20200331967
    Abstract: The peptide of the present invention performs a function, which is the same as or similar to that of natural interleukin (IL)-3, and has superior skin permeability due to the small size thereof. In addition, the peptide of the present invention suppresses the activation of NF-?B and nuclear transition by inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL)-RANK signaling pathway, and suppresses the expression of a RANKL or an inflammatory cytokine-induced tartrate-resistant acid phosphatase (TRAP), cathepsin K, or TNF receptor type 1 or type 2, thereby inhibiting osteoclast differentiation depending on the treatment concentration. Moreover, the peptide of the present invention can contribute to osteoblast differentiation by promoting the expression of osteoblast differentiation markers such as osteocalcin (OCN), osteoprotegerin (OPG), bone sialoprotein (BSP), or osteopontin (OPN).
    Type: Application
    Filed: April 21, 2020
    Publication date: October 22, 2020
    Inventors: Yong Ji CHUNG, Eun Mi Kim, Eung Ji Lee, Tae-Hoon Lee, A-Reum Han
  • Patent number: 10779950
    Abstract: A knee joint implant that prevents hyperextension includes a femoral component having an anterior surface with reference to the lowermost point of a convex condyle, the anterior surface being configured to have different curvature radii in respective sections thereof, and a bearing component having an anterior surface with reference to the lowermost point of a concave articular surface, the anterior surface being configured to have different curvature radii in respective sections, so that when an extended knee is about to be hyperextended, the convex condyle of the femoral component slides toward the anterior side and is brought into contact with a plurality of points of the concave articular surface of the bearing component, thereby producing resistance so as to suppress hyperextension exceeding a design range due to behavioral habits, a decrease in muscle mass, and the like of the patient.
    Type: Grant
    Filed: December 27, 2018
    Date of Patent: September 22, 2020
    Assignee: Corentec Co. Ltd.
    Inventors: Young-Woong Jang, Chan-Eol Kim, Jae-Hun Ro, Ah-Reum Han, Myung-Chul Lee, Yong In, Seung-Beon Han
  • Patent number: 10669312
    Abstract: The peptide of the present invention performs a function, which is the same as or similar to that of natural interleukin (IL)-3, and has superior skin permeability due to the small size thereof. In addition, the peptide of the present invention suppresses the activation of NF-?B and nuclear transition by inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL)-RANK signaling pathway, and suppresses the expression of a RANKL or an inflammatory cytokine-induced tartrate-resistant acid phosphatase (TRAP), cathepsin K, or TNF receptor type 1 or type 2, thereby inhibiting osteoclast differentiation depending on the treatment concentration. Moreover, the peptide of the present invention can contribute to osteoblast differentiation by promoting the expression of osteoblast differentiation markers such as osteocalcin (OCN), osteoprotegerin (OPG), bone sialoprotein (BSP), or osteopontin (OPN).
    Type: Grant
    Filed: January 19, 2018
    Date of Patent: June 2, 2020
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong-Ji Chung, Eun-Mi Kim, Eung-Ji Lee, Tae-Hoon Lee, A-Reum Han
  • Publication number: 20200046507
    Abstract: A knee joint implant that prevents hyperextension includes a femoral component having an anterior surface with reference to the lowermost point of a convex condyle, the anterior surface being configured to have different curvature radii in respective sections thereof, and a bearing component having an anterior surface with reference to the lowermost point of a concave articular surface, the anterior surface being configured to have different curvature radii in respective sections, so that when an extended knee is about to be hyperextended, the convex condyle of the femoral component slides toward the anterior side and is brought into contact with a plurality of points of the concave articular surface of the bearing component, thereby producing resistance so as to suppress hyperextension exceeding a design range due to behavioral habits, a decrease in muscle mass, and the like of the patient.
    Type: Application
    Filed: December 27, 2018
    Publication date: February 13, 2020
    Inventors: Young-Woong Jang, Chan-Eol Kim, Jae-Hun Ro, Ah-Reum Han, Myung-Chul Lee, Yong In, Seung-Beon Han
  • Publication number: 20200046506
    Abstract: An artificial knee joint includes a tibial component implanted into the proximal end of a tibia, and a bearing component coupled to the tibial component, in which the tibial component includes an interference prevention portion capable of preventing interference with the bearing component when the bearing component is inserted diagonally and the bearing component includes a protrusion coupled to the interference prevention portion.
    Type: Application
    Filed: December 27, 2018
    Publication date: February 13, 2020
    Inventors: Young-Woong Jang, Chan-Eol Kim, Jae-Hun Ro, Ah-Reum Han, Myung-Chul Lee, Yong In, Seung-Beon Han
  • Publication number: 20190173170
    Abstract: Disclosed is a pedestal apparatus having an antenna attached thereto capable of biaxial motion. The pedestal apparatus according to one embodiment may comprise: a body; a first drive unit, arranged on the lower part of the body, for transmitting driving power; a second drive unit, arranged on the lower part of the body, for transmitting driving power; a first drive gear arranged on the upper part of the body and receiving driving power from the first drive unit; a second drive gear arranged on the upper part of the body opposite the first drive gear, and receiving driving power from the second drive unit; and a driven gear which rotates by receiving driving power from the first and second drive gears, and to which an antenna is connected, wherein the antenna can move biaxially in accordance with the rotational directions of the first and second drive gears.
    Type: Application
    Filed: June 30, 2016
    Publication date: June 6, 2019
    Applicant: INTELLIAN TECHNOLOGIES, INC.
    Inventors: Hyun Uk Lee, A Reum Han
  • Patent number: 10238710
    Abstract: Provided is a peptide, which has an anti-inflammatory activity and an activity for promoting osteogenic differentiation, formed from the amino acid sequence selected from the group comprising the amino acid sequences of SEQ ID NO: 1, SEQ ID NO: 2, and SEQ ID NO: 3. And provided is a peptide, which has a hair growth promoting activity, formed from the amino acid sequence selected from the group comprising the amino acid sequences of SEQ ID NO: 1 and SEQ ID NO: 2. A peptide formed from the amino acid sequence of SEQ ID NO: 1, SEQ ID NO: 2, or SEQ ID NO: 3, according to the present invention, consequently shows an anti-inflammatory activity by inhibiting an inflammatory cytokine expression and proliferation of inflammatory cells, and consequently promotes osteogenic differentiation by increasing phosphorylation of PI3K, Smad1, Smad5 and Smad8, which contribute to osteogenesis, and by increasing ALP, OPG and BSP expressions.
    Type: Grant
    Filed: November 21, 2014
    Date of Patent: March 26, 2019
    Assignee: CAREGEN CO., LTD.
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung Ji Lee, Kyoung Mi Cho, A Reum Han
  • Patent number: 10030050
    Abstract: A peptide which is formed from an amino acid sequence selected from the group comprising amino acid sequences of SEQ ID NO: 1 to SEQ ID NO: 3, according to the present invention, has osteoclast differentiation and activation inhibition and is highly effective for preventing or treating bone diseases related to the destruction of the bone. A peptide, according to the present invention, reduces expression of cathepsin K and TRAP related to osteoclast differentiation, inhibits nuclear translocation of NF-kB, and ultimately inhibits osteoclast differentiation. Provided is a composition, for preventing or treating bone diseases, comprising the peptide.
    Type: Grant
    Filed: August 5, 2014
    Date of Patent: July 24, 2018
    Inventors: Yong Ji Chung, Eun Mi Kim, Eung Ji Lee, A Reum Han, Hyun Jung Kwon
  • Publication number: 20180170966
    Abstract: The peptide of the present invention performs a function, which is the same as or similar to that of natural interleukin (IL)-3, and has superior skin permeability due to the small size thereof. In addition, the peptide of the present invention suppresses the activation of NF-?B and nuclear transition by inhibiting the receptor activator of nuclear factor kappa-B ligand (RANKL)-RANK signaling pathway, and suppresses the expression of a RANKL or an inflammatory cytokine-induced tartrate-resistant acid phosphatase (TRAP), cathepsin K, or TNF receptor type 1 or type 2, thereby inhibiting osteoclast differentiation depending on the treatment concentration. Moreover, the peptide of the present invention can contribute to osteoblast differentiation by promoting the expression of osteoblast differentiation markers such as osteocalcin (OCN), osteoprotegerin (OPG), bone sialoprotein (BSP), or osteopontin (OPN).
    Type: Application
    Filed: January 19, 2018
    Publication date: June 21, 2018
    Inventors: Yong-Ji CHUNG, Eun-Mi KIM, Eung-Ji LEE, Tae-Hoon LEE, A-Reum HAN